Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piperacillin/tazobactam for ESBL control
NCT00254696Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jun 2004
- Primary completion
- Mar 2005
- Modality
- Irreversible Covalent Inhibitors
01
Overview
A Phase 4 trial of piperacillin + tazobactam in bacterial infection, sponsored by Pfizer. Started Jun 2004; status: completed.
02
Drugs
piperacillin + tazobactam
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT00254696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254696.